Efficacy of Non-ablative Radiofrequency Combined With Pelvic Floor Muscle Training for Genitourinary Syndrome of Menopause in Breast Cancer Survivors (RF-SGM)
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
With
Hospital Universitario Ramon y Cajal
Age
18–75
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Women who are breast cancer survivors and clinically confirmed to be disease-free by their physician.
Amenorrhea for more than 12 months and vaginal pH ≥ 5, with symptoms related to genitourinary syndrome of menopause (GSM), as diagnosed by a physician. Symptoms must be bothersome and not better explained by another clinical condition.
Negative urine culture at baseline.
Moderate to severe vaginal dryness, defined as a score \> 4 on the Numeric Rating Scale (NRS 0-10)
You may not be if
Age over 75 years.
Current or past diagnosis of any cancer other than breast cancer.
Pelvic surgery, chemotherapy, or radiotherapy in the past 3 months.
Use of local estrogen therapy within the past month.
Active genital infections.
Diagnosis of HIV infection or severe immunosuppression.
Presence of pacemakers, metallic implants, or electromagnetic devices.
Coagulation disorders or current use of anticoagulants.
Pelvic organ prolapse stage \> III (POP-Q classification).
Unexplained abnormal vaginal bleeding.
History of pelvic anti-incontinence surgery, with or without mesh.
Inflammatory dermatoses of the vulva.
Pelvic-floor muscle strength score of 0/5 on the Modified Oxford Scale.
Nickel allergy.
Previous treatment with radiofrequency in the pelvic or genital area.
Clareo Health | Efficacy of Non-ablative Radiofrequency Combined With Pelvic Floor Muscle Training for Genitourinary Syndrome of Menopause in Breast Cancer Survivors (RF-SGM)
